{
    "2021-03-09": [
        [
            {
                "time": "",
                "original_text": "首创证券-----医药商业行业深度报告：政策利好叠加疫情催化，零售药店迎来发展契机【行业研究】",
                "features": {
                    "keywords": [
                        "政策利好",
                        "疫情催化",
                        "零售药店",
                        "发展契机"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "【华创消费】机会在哪里？食品饮料对话医药健康",
                "features": {
                    "keywords": [
                        "机会",
                        "食品饮料",
                        "医药健康"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "食品饮料",
                        "医药健康"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "益丰药房现2笔大宗交易总成交金额501.17万元",
                "features": {
                    "keywords": [
                        "益丰药房",
                        "大宗交易",
                        "成交金额"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "益丰药房今日大宗交易成交6.36万股，成交价78.8元溢价0.0%",
                "features": {
                    "keywords": [
                        "益丰药房",
                        "大宗交易",
                        "成交价",
                        "溢价"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "医药行业周报：逐步布局一季报高增长核心资产",
                "features": {
                    "keywords": [
                        "医药行业",
                        "一季报",
                        "高增长",
                        "核心资产"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "国盛证券-----医药生物行业周报：全民免疫迫在眉睫，新冠疫苗的热点问题怎么看【行业研究】",
                "features": {
                    "keywords": [
                        "医药生物",
                        "全民免役",
                        "新冠疫苗",
                        "热点问题"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "西南证券-----医药行业周报：核心资产性价比在提升，同时关注PEG投资机会【行业研究】",
                "features": {
                    "keywords": [
                        "医药行业",
                        "核心资产",
                        "性价比",
                        "PEG投资机会"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}